Song MK, Bischoff DS, Song AM, Uyemura K, Yamaguchi DT (2017) Metabolic relationship between diabetes and Alzheimer's Disease affected by Cyclo(His-Pro) plus zinc treatment. BBA Clin 7:41–54. https://doi.org/10.1016/j.bbacli.2016.09.003S2214-6474(16)30039-3
Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I et al (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95(11):6448–6453
Article CAS PubMed PubMed Central Google Scholar
Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416(6880):535–539. https://doi.org/10.1038/416535a416535a]
Article CAS PubMed Google Scholar
Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA et al (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14(8):837–842. https://doi.org/10.1038/nm1782
Article CAS PubMed PubMed Central Google Scholar
Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440(7082):352–357. https://doi.org/10.1038/nature04533
Article CAS PubMed Google Scholar
Miyauchi T, Hagimoto H, Ishii M, Endo S, Tanaka K, Kajiwara S, Endo K, Kajiwara A et al (1994) Quantitative EEG in patients with presenile and senile dementia of the Alzheimer type. Acta Neurol Scand 89(1):56–64
Article CAS PubMed Google Scholar
Brunovsky M, Matousek M, Edman A, Cervena K, Krajca V (2003) Objective assessment of the degree of dementia by means of EEG. Neuropsychobiology 48(1):19–26. https://doi.org/10.1159/000071824
de la Monte SM, Wands JR (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis 7(1):45–61. https://doi.org/10.3233/jad-2005-7106
Schuh AF, Rieder CM, Rizzi L, Chaves M, Roriz-Cruz M (2011) Mechanisms of brain aging regulation by insulin: implications for neurodegeneration in late-onset Alzheimer's disease. ISRN Neurol 2011:306905. https://doi.org/10.5402/2011/306905
Article CAS PubMed PubMed Central Google Scholar
Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8(2):101–112. https://doi.org/10.1038/nrm2101
Article CAS PubMed Google Scholar
Ferreira ST, Vieira MN, De Felice FG (2007) Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases. IUBMB Life 59(4-5):332–345. https://doi.org/10.1080/15216540701283882
Article CAS PubMed Google Scholar
Ferreira ST, Klein WL (2011) The Abeta oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease. Neurobiol Learn Mem 96(4):529–543. https://doi.org/10.1016/j.nlm.2011.08.003
Article CAS PubMed PubMed Central Google Scholar
Xie L, Helmerhorst E, Taddei K, Plewright B, Van Bronswijk W, Martins R (2002) Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci 22(10):RC221
Article PubMed PubMed Central Google Scholar
Zhao WQ, De Felice FG, Fernandez S, Chen H, Lambert MP, Quon MJ, Krafft GA, Klein WL (2008) Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J 22(1):246–260. https://doi.org/10.1096/fj.06-7703com
Article CAS PubMed Google Scholar
De Felice FG, Vieira MN, Bomfim TR, Decker H, Velasco PT, Lambert MP, Viola KL, Zhao WQ et al (2009) Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci U S A 106(6):1971–1976. https://doi.org/10.1073/pnas.0809158106
Article PubMed PubMed Central Google Scholar
Lane RF, Shineman DW, Steele JW, Lee LB, Fillit HM (2012) Beyond amyloid: the future of therapeutics for Alzheimer's disease. Adv Pharmacol 64:213–271. https://doi.org/10.1016/B978-0-12-394816-8.00007-6
Article CAS PubMed Google Scholar
Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27(4):796–807. https://doi.org/10.1523/JNEUROSCI.3501-06.2007
Article CAS PubMed PubMed Central Google Scholar
Escribano L, Simon AM, Gimeno E, Cuadrado-Tejedor M, Lopez de Maturana R, Garcia-Osta A, Ricobaraza A, Perez-Mediavilla A et al (2010) Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology. Neuropsychopharmacology 35(7):1593–1604. https://doi.org/10.1038/npp.2010.32
Article CAS PubMed PubMed Central Google Scholar
Jha NK, Jha SK, Kumar D, Kejriwal N, Sharma R, Ambasta RK, Kumar P (2015) Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications. J Alzheimers Dis 48(4):891–917. https://doi.org/10.3233/JAD-150379
Article CAS PubMed Google Scholar
Pivovarova O, Hohn A, Grune T, Pfeiffer AF, Rudovich N (2016) Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease? Ann Med 48(8):614–624. https://doi.org/10.1080/07853890.2016.1197416
Article CAS PubMed Google Scholar
Morales-Corraliza J, Wong H, Mazzella MJ, Che S, Lee SH, Petkova E, Wagner JD, Hemby SE et al (2016) Brain-Wide Insulin Resistance, Tau Phosphorylation Changes, and Hippocampal Neprilysin and Amyloid-beta Alterations in a Monkey Model of Type 1 Diabetes. J Neurosci 36(15):4248–4258. https://doi.org/10.1523/JNEUROSCI.4640-14.2016
Article CAS PubMed PubMed Central Google Scholar
Miao X, Sun W, Fu Y, Miao L, Cai L (2013) Zinc homeostasis in the metabolic syndrome and diabetes. Front Med 7(1):31–52. https://doi.org/10.1007/s11684-013-0251-9
Lifshitz V, Benromano T, Weiss R, Blanga-Kanfi S, Frenkel D (2013) Insulin-degrading enzyme deficiency accelerates cerebrovascular amyloidosis in an animal model. Brain Behav Immun 30:143–149. https://doi.org/10.1016/j.bbi.2012.12.003
Article CAS PubMed Google Scholar
Roberts RO, Knopman DS, Geda YE, Cha RH, Pankratz VS, Baertlein L, Boeve BF, Tangalos EG et al (2014) Association of diabetes with amnestic and nonamnestic mild cognitive impairment. Alzheimers Dement 10(1):18–26. https://doi.org/10.1016/j.jalz.2013.01.001
Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, de Boer IH (2016) Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014. JAMA 316(6):602–610. https://doi.org/10.1001/jama.2016.10924
Article PubMed PubMed Central Google Scholar
Watt NT, Whitehouse IJ, Hooper NM (2010) The role of zinc in Alzheimer's disease. Int J Alzheimers Dis 2011:971021. https://doi.org/10.4061/2011/971021
Article CAS PubMed PubMed Central Google Scholar
Borza DB, Morgan WT (1998) Histidine-proline-rich glycoprotein as a plasma pH sensor. Modulation of its interaction with glycosaminoglycans by ph and metals. J Biol Chem 273(10):5493–5499. https://doi.org/10.1074/jbc.273.10.5493
Article CAS PubMed Google Scholar
Rosenthal MJ, Hwang IK, Song MK (2001) Effects of arachidonic acid and cyclo (his-pro) on zinc transport across small intestine and muscle tissues. Life Sci 70(3):337–348. https://doi.org/10.1016/s0024-3205(01)01395-9
Article CAS PubMed Google Scholar
Maher PA, Schubert DR (2009) Metabolic links between diabetes and Alzheimer's disease. Expert Rev Neurother 9(5):617–630. https://doi.org/10.1586/ern.09.18
Article CAS PubMed Google Scholar
Banks WA, Kastin AJ, Jaspan JB (1992) Orally administered cyclo(His-Pro) reduces ethanol-induced narcosis in mice. Pharmacol Biochem Behav 43(3):939–941. https://doi.org/10.1016/0091-3057(92)90428-i
Article CAS PubMed Google Scholar
Banks WA, Kastin AJ, Akerstrom V, Jaspan JB (1993) Radioactively iodinated cyclo(His-Pro) crosses the blood-brain barrier and reverses ethanol-induced narcosis. Am J Physiol 264(5 Pt 1):E723–E729. https://doi.org/10.1152/ajpendo.1993.264.5.E723
Article CAS PubMed Google Scholar
Jaspan JB, Banks WA, Kastin AJ (1994) Study of passage of peptides across the blood-brain barrier: biological effects of cyclo(His-Pro) after intravenous and oral administration. Ann N Y Acad Sci 739:101–107. https://doi.org/10.1111/j.1749-6632.1994.tb19811.x
Article CAS PubMed Google Scholar
Song MK, Rosenthal MJ, Song AM, Uyemura K, Yang H, Ament ME, Yamaguchi DT, Cornford EM (2009) Body weight reduction in rats by oral treatment with zinc plus cyclo-(His-Pro). Br J Pharmacol 158(2):442–450. https://doi.org/10.1111/j.1476-5381.2009.00201.x
留言 (0)